|
Home : Unsafe Drugs : Avandia : Newsfeeds : Unfinished Agenda: Kallam Anji Reddy sets lofty targets for philanthropy Unfinished Agenda: Kallam Anji Reddy sets lofty targets for philanthropy
This target fell out of favour, particularly after GlaxoSmithKline's PPAR drug Avandia was associated with cardiovascular events. As a result, Dr Reddy's is unable to license balaglitazone , also in the same class. Its other PPAR drug ragaglitazar ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




